These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6675885)

  • 21. Clinical trials of platelet-active drugs in coronary heart disease: summary of design features.
    Furberg CD; May GS
    Circulation; 1980 Dec; 62(6 Pt 2):V49-52. PubMed ID: 7002352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease modifying trials in Alzheimer disease: methodological and statistical issues.
    Andrieu S; Rascol O; Lang T; Grandjean H; Vellas B
    J Nutr Health Aging; 2006; 10(2):116-7. PubMed ID: 16554944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary stenosis significance: lessons learned from recent trials.
    Vogel RA
    Curr Opin Cardiol; 1994 Nov; 9(6):705-8. PubMed ID: 7819630
    [No Abstract]   [Full Text] [Related]  

  • 24. How to design a clinical trial.
    Curtis BM; Barrett BJ; Parfrey PS
    Methods Mol Med; 2003; 86():475-89. PubMed ID: 12886789
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical end points in coronary stent trials: a case for standardized definitions.
    Cutlip DE; Windecker S; Mehran R; Boam A; Cohen DJ; van Es GA; Steg PG; Morel MA; Mauri L; Vranckx P; McFadden E; Lansky A; Hamon M; Krucoff MW; Serruys PW;
    Circulation; 2007 May; 115(17):2344-51. PubMed ID: 17470709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Issues in clinical trials of prophylaxis of fungal infections.
    Powers JH
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S211-7. PubMed ID: 15546120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of futility in clinical trials.
    Snapinn S; Chen MG; Jiang Q; Koutsoukos T
    Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trial design issues in schizophrenic research.
    Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 9():17-20; discussion 21-2. PubMed ID: 11379826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing accrual in cooperative group clinical trials.
    Demmy TL; Yasko JM; Collyar DE; Katz ML; Krasnov CL; Borwhat MJ; Battershell A; George SL
    J Clin Oncol; 2004 Aug; 22(15):2997-3002. PubMed ID: 15284251
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical trial of Cardiocap in coronary insufficiency].
    Baronti G; Del Corso P; Romboli L
    Minerva Cardioangiol; 1974 May; 22(5):344-55. PubMed ID: 4619188
    [No Abstract]   [Full Text] [Related]  

  • 31. Methods of testing feasibility for sequenced treatment alternatives to relieve depression (STAR*D).
    Wisniewski SR; Stegman D; Trivedi M; Husain MM; Eng H; Shores-Wilson K; Luther J; Biggs MM; Burroughs D; Ritz AL; Fava M; Quitkin F; Rush AJ;
    J Psychiatr Res; 2004; 38(3):241-8. PubMed ID: 15003429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Unicenter versus multicenter clinical trials].
    Nogueira de Rojas JR
    Rev Invest Clin; 1990 Jul; 42 Suppl():39-42. PubMed ID: 19256132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Explanatory versus pragmatic trials? The methods make the difference.
    Merckx P; Paugam-Burtz C; Boudinet S; Bonnet A; Mantz J
    Anesthesiology; 2008 Mar; 108(3):542-3; author reply 543-4. PubMed ID: 18292699
    [No Abstract]   [Full Text] [Related]  

  • 34. A study to remember: response of the Project MATCH Research Group.
    Addiction; 1999 Jan; 94(1):66-9. PubMed ID: 10665098
    [No Abstract]   [Full Text] [Related]  

  • 35. The final dose of clinical trial designs.
    Wyllie MG
    BJU Int; 2004 Oct; 94(6):929-30. PubMed ID: 15476538
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical considerations in the design of clinical trials.
    Carter SK
    Cancer Treat Rep; 1980; 64(2-3):367-71. PubMed ID: 7407773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical development of atypical antipsychotics: research design and evaluation. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():10-6. PubMed ID: 9766614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Coronary Drug Project. Further aspects of data analysis.
    Canner PL
    Control Clin Trials; 1983 Dec; 4(4):485-503. PubMed ID: 6675897
    [No Abstract]   [Full Text] [Related]  

  • 40. Depression and coronary artery disease: time to move from observation to trials.
    Lespérance F; Frasure-Smith N
    CMAJ; 2003 Mar; 168(5):570-1. PubMed ID: 12615752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.